NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 31 filers reported holding NRX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 3,220 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -50.0% | 3,220 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | -33.3% | 3,220 | -8.5% | 0.00% | – |
| Q4 2022 | $3 | -99.8% | 3,520 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 3,520 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -85.7% | 3,520 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -88.9% | 3,520 | -83.1% | 0.00% | -100.0% |
| Q4 2021 | $63,000 | -64.0% | 20,819 | -53.9% | 0.00% | -71.4% |
| Q3 2021 | $175,000 | – | 45,151 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 699,731 | $338,320 | 0.28% |
| CVI Holdings, LLC | 483,569 | $233,806 | 0.25% |
| ARMISTICE CAPITAL, LLC | 5,636,000 | $2,725,006 | 0.04% |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $30,601 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $77,698 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $14,133 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $8,848 | 0.00% |
| JANE STREET GROUP, LLC | 15,052 | $7,278 | 0.00% |
| UBS Group AG | 2,758 | $1,332 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,028 | 0.00% |